These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 31612847)

  • 1. Ketamine and Treatment-Resistant Depression.
    Lent JK; Arredondo A; Pugh MA; Austin PN
    AANA J; 2019 Oct; 87(5):411-419. PubMed ID: 31612847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression.
    Phillips JL; Norris S; Talbot J; Hatchard T; Ortiz A; Birmingham M; Owoeye O; Batten LA; Blier P
    Neuropsychopharmacology; 2020 Mar; 45(4):606-612. PubMed ID: 31759333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
    Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
    Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine as treatment for depression.
    Taiminen T
    Duodecim; 2017; 133(1):52-60. PubMed ID: 29199810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.
    Phillips JL; Norris S; Talbot J; Birmingham M; Hatchard T; Ortiz A; Owoeye O; Batten LA; Blier P
    Am J Psychiatry; 2019 May; 176(5):401-409. PubMed ID: 30922101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociative symptoms with intravenous ketamine in treatment-resistant depression exploratory observational study.
    Włodarczyk A; Cubała WJ; Gałuszko-Węgielnik M; Szarmach J
    Medicine (Baltimore); 2021 Jul; 100(29):e26769. PubMed ID: 34398056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.
    De Gioannis A; De Leo D
    Aust N Z J Psychiatry; 2014 Jul; 48(7):686. PubMed ID: 24452289
    [No Abstract]   [Full Text] [Related]  

  • 8. Ketamine versus electroconvulsive therapy for treatment-resistant depression: An updated meta-analysis of randomized clinical trials.
    Shafiee A; Soltani Abhari F; Jafarabady K; Bakhtiyari M
    Asian J Psychiatr; 2023 Oct; 88():103720. PubMed ID: 37572523
    [No Abstract]   [Full Text] [Related]  

  • 9. Promises and concerns regarding the use of ketamine and esketamine in the treatment of depression.
    Pérez-Esparza R; Kobayashi-Romero LF; García-Mendoza AM; Lamas-Aguilar RM; Fonseca-Perezamador A
    Acta Psychiatr Scand; 2019 Aug; 140(2):182-183. PubMed ID: 31251388
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness of ketamine in depressed patients resistant to ECT or rTMS therapy].
    Gosek P; Chojnacka M; Bieńkowski P; Swiecicki Ł
    Psychiatr Pol; 2014; 48(1):49-58. PubMed ID: 24946434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of oral ketamine augmentation on hospital admissions in treatment-resistant depression and PTSD: a retrospective study.
    Hartberg J; Garrett-Walcott S; De Gioannis A
    Psychopharmacology (Berl); 2018 Feb; 235(2):393-398. PubMed ID: 29151192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of ketamine in electroconvulsive therapy.
    Kucia K; Merk W
    Psychiatr Pol; 2015; 49(6):1255-63. PubMed ID: 26909400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous ketamine infusion for a patient with treatment-resistant major depression: a 10-month follow-up.
    Kwon JH; Sim WS; Hong JP; Song IS; Lee JY
    J Clin Pharm Ther; 2018 Aug; 43(4):581-583. PubMed ID: 29372569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression.
    Singh JB; Fedgchin M; Daly EJ; De Boer P; Cooper K; Lim P; Pinter C; Murrough JW; Sanacora G; Shelton RC; Kurian B; Winokur A; Fava M; Manji H; Drevets WC; Van Nueten L
    Am J Psychiatry; 2016 Aug; 173(8):816-26. PubMed ID: 27056608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ketamine on major depressive disorder in a patient with posttraumatic stress disorder.
    Womble AL
    AANA J; 2013 Apr; 81(2):118-9. PubMed ID: 23971230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation Therapy With Serial Intravenous Ketamine Over 18 Months in a Patient With Treatment Resistant Depression.
    Hassamal S; Spivey M; Pandurangi AK
    Clin Neuropharmacol; 2015; 38(5):212-6. PubMed ID: 26366968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiety during ketamine infusions is associated with negative treatment responses in major depressive disorder.
    Aust S; Gärtner M; Basso L; Otte C; Wingenfeld K; Chae WR; Heuser-Collier I; Regen F; Cosma NC; van Hall F; Grimm S; Bajbouj M
    Eur Neuropsychopharmacol; 2019 Apr; 29(4):529-538. PubMed ID: 30772118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation.
    Cusin C; Ionescu DF; Pavone KJ; Akeju O; Cassano P; Taylor N; Eikermann M; Durham K; Swee MB; Chang T; Dording C; Soskin D; Kelley J; Mischoulon D; Brown EN; Fava M
    Aust N Z J Psychiatry; 2017 Jan; 51(1):55-64. PubMed ID: 26893373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial.
    Correia-Melo FS; Leal GC; Carvalho MS; Jesus-Nunes AP; Ferreira CBN; Vieira F; Magnavita G; Vale LAS; Mello RP; Nakahira C; Argolo FC; Cardoso T; Souza CDS; Fontes ATC; Ferreira MB; Araújo-de-Freitas L; Tuena MA; Echegaray MVF; Cavalcanti DE; Lucchese AC; Bandeira ID; Telles M; Lima CS; Sampaio AS; Silva SS; Marback RF; Del-Porto JA; Abreu JN; Sarin LM; Paixão CS; Carvalho LP; Machado PRL; Turecki G; Lacerda ALT; Quarantini LC
    Medicine (Baltimore); 2018 Sep; 97(38):e12414. PubMed ID: 30235716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.
    Murrough JW; Perez AM; Pillemer S; Stern J; Parides MK; aan het Rot M; Collins KA; Mathew SJ; Charney DS; Iosifescu DV
    Biol Psychiatry; 2013 Aug; 74(4):250-6. PubMed ID: 22840761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.